Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 11/20 | 0.55 |
| ▸ | HTR7 | P34969 | 8/20 | 0.55 |
| ▸ | DRD2 | P14416 | 10/20 | 0.54 |
| ▸ | HTR6 | P50406 | 6/20 | 0.54 |
| ▸ | HTR1A | P08908 | 3/20 | 0.52 |
| ▸ | DRD4 | P21917 | 1/20 | 0.52 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24279780 | 0.83 | HTR2A (0.58) | HTR2AHTR7DRD2HTR6HTR1A | |
| SCHEMBL21678217 | 0.80 | DRD2 (0.57) | HTR2AHTR7DRD2HTR1ADRD4 | |
| SCHEMBL24279786 | 0.78 | DRD2 (0.57) | HTR2AHTR7DRD2HTR1A | |
| SCHEMBL793276 | 0.78 | DRD2 (0.60) | HTR2AHTR7DRD2HTR6HTR1A | |
| SCHEMBL14046594 | 0.78 | SORD (0.54) | HTR2AHTR7DRD2HTR1A | |
| SCHEMBL793052 | 0.77 | DRD2 (0.62) | HTR2AHTR7DRD2HTR6HTR1A | |
| SCHEMBL23595834 | 0.77 | HTR2A (0.58) | HTR2AHTR7DRD2HTR6HTR1A | |
| SCHEMBL2734694 | 0.76 | HTR2A (0.51) | HTR2AHTR7DRD2HTR1ADRD4 | |
| Hydrochloric Acid SCHEMBL23581608 | 0.76 | HTR2A (0.57) | HTR2AHTR7DRD2HTR6HTR1A | |
| SCHEMBL24668455 | 0.76 | HTR2A (0.76) | HTR2AHTR7DRD2HTR1ADRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4082616-A1 | ALIPHATIC ACID AMIDE DERIVATIVE | Sumitomo Pharma Co., Ltd. (JP) | 2022-11-02 | — | — | EP | disclosed |
| US-20220213079-A1 | ALIPHATIC ACID AMIDE DERIVATIVE | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2022-07-07 | — | — | US | disclosed |
| US-11339151-B2 | Aliphatic acid amide derivative | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2022-05-24 | — | — | US | disclosed |
| US-20220073506-A1 | ALIPHATIC ACID AMIDE DERIVATIVE | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2022-03-10 | — | — | US | disclosed |
| WO-2021132311-A1 | ALIPHATIC ACID AMIDE DERIVATIVE | 大日本住友製薬株式会社 | 2021-07-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11339151-B2 | Aliphatic acid amide derivative | HTR2A, HTR1A, HTR7 | HTR2A 1/4885HTR7 3/4885DRD2 15/4885 |
| US-20220213079-A1 | ALIPHATIC ACID AMIDE DERIVATIVE | HTR2A, HTR1A, HTR7 | HTR2A 1/4885HTR7 3/4885DRD2 15/4885 |
| US-20220073506-A1 | ALIPHATIC ACID AMIDE DERIVATIVE | HTR2A, HTR1A, HTR7 | HTR2A 1/4885HTR7 3/4885DRD2 15/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.